Barcelona Here We Come! 🇪🇸


Barcelona get ready! 😍

Hola! We’re missing good tapas so we’re off to Barcelona!

Barcelona 🇪🇸 is one of the biotech hotspots in Europe with awesome companies such as Oryzon Genomics, Minoryx Therapeutics, Chemotargets & Laboratorios Rubió.

So, you’re invited to join us and the rest of the Barcelona biotech gang for a relaxed biotech Meetup on the 📝21st of May 2019📝!

Get ready to meet some great people, listen to some awesome speakers, and enjoy some free beers 🍻. You will be able to find us at Movistar Centre in Plaça de Catalunya looking super cool in our Labiotech t-shirts.

Thanks to Biocat for being such a cool co-host and NIBC and JLABS for supporting us 😉


Raúl Martín-Ruiz, Partner at Ysios Capital

Raúl has been investing in biotech companies for over 10 years as a partner in Ysios Capital, Spain’s most influential life sciences VC. He’s on the board of several biotech companies in the Barcelona area, including STAT-Dx, Anaconda BioMed and MedLumics.

José Luis Cabero, CEO of Aelix Therapeutics

José is the CEO of Aelix Therapeutics, a biotech company based in Barcelona developing a vaccine against HIV infections. He has over 25 years of experience in the management of several biotech companies as well as AstraZeneca.

What to expect?

  • Relaxed biotech event
  • 2 fireside chats with awesome speakers
  • Networking opportunities with the biotechnologists in your area
  • 70 attendees
  • Free entry
  • Free beers and snacks
  • The unique Refresh vibe

Remember to leave your tie/blazers at home so you can chill out and be a biotech nerd in comfort.


Check out what happened in Vienna:

What happens if I miss out on this Refresh?

See what we’re up to next by subscribing to our lovely newsletter 😊

If you have any questions then feel free to send me a message at

Support good journalism, subscribe to Labiotech Insider

Labiotech Insider

If you liked this post and want to read more good journalism, support us by joining Labiotech Insider. Our Insider membership gives you access to exclusive content and other advantages.